IL6 and lung carcinoma: Ultimately, lower lymphocyte level could be used as an ancillary marker for diagnosis and severity in lung cancer patients, especially in centers where more expensive tests such as d-dimer, interleukin-6, and ferritin are not feasible for routine practice (5).